F

Fresenius Medical Care

Operates dialysis facilities and renal care

Injection Molding Engineer

Full-TimeDeadline 12/31/26
No salary listed
Senior
Bachelor's
Suzhou, Jiangsu, China
In Person
Manufacturing & Process EngineeringManufacturing Engineering

About the job

Requirements
  • A mechanical engineering degree and experience in a production field.
  • At least five years of experience in the business and in the molding process.
  • Knowledge of current injection molding machine technologies on the market.
  • Work experience in a Good Manufacturing Practice (GMP) environment.
  • Skills related to dialysis products.
  • Knowledge of two-dimensional and three-dimensional computer-aided design (CAD) drawing.
  • Bilingual written and spoken proficiency in English and German.
  • Ability to travel.
Responsibilities
  • Execute, plan, and schedule projects.
  • Ensure capital expenditure (CAPEX) investments are spent on time.
  • Participate in the development and implementation of new technologies.
  • Support smooth technology transfer of molds and injection molding machines.
  • Participate in standardizing best practices in injection molding.
  • Participate in global projects.
  • Support value streams in evaluating moldability and costs during product development.
  • Create user requirement specifications (URS) for injection molding-related equipment.
  • Engage suppliers and vendors to coordinate the bidding process with Procurement.
  • Lead concept and design reviews with internal process owners and potential external suppliers.
  • Lead design qualification (DQ), factory acceptance testing (FOT and FAT), site acceptance testing (SAT), installation qualification (IQ), and operational qualification (OQ) for CAPEX projects.
  • Lead equipment implementation.
  • Monitor and report CAPEX expenditure for each project.

About the company

F

Fresenius Medical Care

View

Fresenius Medical Care North America runs a network of dialysis facilities and outpatient labs to deliver coordinated kidney care for hundreds of thousands of patients. It also offers specialty pharmacy and laboratory services and manufactures a wide range of dialysis equipment, disposables, and renal drugs. The company treats patients by providing dialysis and related care at its clinics, supported by the equipment, supplies, and medicines it develops and distributes. FMCNA differentiates itself through its size and integration as the world's largest fully integrated renal company, with a nationwide network covering care delivery, drugs, labs, and manufacturing, aiming to provide high-quality, convenient access to comprehensive services across North America.

Company Size

11-50

Company Stage

Late Stage VC

Total Funding

$40.2M

Headquarters

Waltham, Massachusetts

Founded

1996

Get referred to Fresenius Medical Care

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 operating income rose 23%, showing transformation gains reached profitability.
  • FME25+ delivered EUR 67 million savings in Q2 2026 and targets EUR 1.2 billion.
  • Real-world evidence studies in July and August 2026 strengthen high-volume hemodiafiltration adoption.

What critics are saying

  • The August 2026 outlook disappointed investors after dialysis growth stalled and shares fell 10%.
  • FME25+ closed around 100 U.S. clinics in 2026, risking patient leakage to DaVita.
  • AB 290 litigation and premium-assistance rules threaten U.S. reimbursement economics and legal spend.

What makes Fresenius Medical Care unique

  • Fresenius Medical Care controls dialysis care, equipment, labs, and specialty pharmacy end-to-end.
  • Its 5008X CAREsystem reached around 100 clinics and 100,000 treatments by May 2026.
  • kinexus and TherapyWise deepen its software moat across home dialysis and kidney therapy.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Professional Development Budget
  • Conference Attendance Budget
  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
Business Wire
Mar 28th, 2024
Compsych Corporation Announces 2023 Health At Work Award Winners

CHICAGO--(BUSINESS WIRE)--ComPsych® Corporation, the world’s largest provider of mental health services and GuidanceResources® for life, today announced the honorees of the 2023 Health at Work Awards. Now in its 19th year, the ComPsych Health at Work Awards recognize organizations across a variety of sizes, industries and locations who have prioritized the health and well-being of their employees by providing innovative, multi-platform programs. “We’re thrilled to honor these stellar organizations for the investment they’ve made in building cultures that value employee mental health and wellness,” said Dr. Richard A. Chaifetz, Founder, Chairman and CEO of ComPsych. “In recent years we’ve seen a rise in anxiety as well as people needing to take leaves of absence due to mental health challenges across the workforce

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Feb 12th, 2024
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

U.S. Securities and Exchange Commission
Dec 6th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Home Health Provider
Feb 17th, 2023
Improving Access & Timely Care For Vulnerable Patients Referred To Home Health Via Telehealth Physician Support

Royal Philips (NYSE: PHG AEX: PHIA), a global leader in health technology, today announced the debut of its eCareManager 4.1 enterprise telehealth software at the American Telemedicine...